According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's current earnings are HK$0.13 Billion. In 2025 the company made an earning of HK$0.22 Billion, an increase over its 2024 earnings that were of HK$0.19 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.